EUCTR2008-001606-16-IT进行中（未招募）1 期
An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects with Giant Cell Tumor of Bone - Denosumab 20062004
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- Amgen Inc
- 入组人数
- 532
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Pathologically confirmed giant cell tumor of bone within 1 year before study enrollment
- •Measurable evidence of active disease within 1 year before study enrollment
- •Subjects with surgically unsalvageable disease (eg, sacral, spinal GCT, or multiple lesions including pulmonary metastases) OR subjects whose planned initial surgery includes joint resection, limb amputation, hemipelvectomy or surgical procedure resulting in severe morbidity, other than curettage with complete resection of tumor
- •Karnofsky performance status ≥ 50% (ie, ECOG status 0, 1, pr 2)
- •Before any study-specific procedure is performed, the appropriate written informed consent must be obtained.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Currently receiving other GCT specific treatment (eg, radiation, chemotherapy, or embolization)
- •Concurrent bisphosphonate treatment
- •Known or suspected current diagnosis of underlying malignancy including high-grade sarcoma, osteosarcoma, fibrosarcoma, malignant giant cell sarcoma
- •Known or suspected current diagnosis of non GCT giant cell-rich tumors
- •Known or suspected current diagnosis of brown cell tumor of bone
- •Known diagnosis of second malignancy within the past 5 years
- •Prior history or current evidence of osteonecrosis/osteomyelitis of the jaw
- •Active dental or jaw condition which requires oral surgery
- •Non-healed dental/oral surgery
- •Planned invasive dental procedure for the course of the study
- •Women or men unwilling to use adequate contraceptive measures
- •Thirty days or less since receiving an investigational product
- •Subject has known sensitivity to any of the products to be administered during dosing
- •Subject has any kind of disorder that compromises the ability of the subject to give written informed consent and/or to comply with study procedures
研究者
相似试验
进行中（未招募）
1 期
Safety Study of Denosumab in Subjects With Recurrent or Unresectable Giant Cell Tumor of BoneEUCTR2008-001606-16-GBAmgen Inc532
进行中（未招募）
1 期
Safety Study of Denosumab in Subjects With Recurrent or Unresectable Giant Cell Tumor of BoneGiant cell tumor of bone (GCTB)MedDRA version: 20.0Level: LLTClassification code 10005968Term: Bone giant cell tumorSystem Organ Class: 100000019081EUCTR2008-001606-16-DEAmgen Inc530
进行中（未招募）
不适用
Safety Study of Denosumab in Subjects With Recurrent or Unresectable Giant Cell Tumor of BoneEUCTR2008-001606-16-Outside-EU/EEAAmgen Inc530
进行中（未招募）
1 期
Denosumab in patients with giant cell rich tumors of bone.Aneurysmal bone cysts, giant cell granuloma, other giant cell rich lesions (primary bone, non-malignant)MedDRA version: 20.1Level: LLTClassification code 10018252Term: Giant cell granuloma peripheralSystem Organ Class: 100000004856MedDRA version: 20.0Level: LLTClassification code 10004430Term: Benign osteoblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10008686Term: ChondroblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10008733Term: Chondromyxoid fibromaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10002362Term: Aneurysmal bone cystSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2016-005244-42-NLeiden University Medical Center60
进行中（未招募）
1 期
Safety Study of Denosumab in Subjects With Recurrent or Unresectable Giant Cell Tumor of BoneGiant cell tumor of bone (GCTB)MedDRA version: 20.0Level: LLTClassification code 10005968Term: Bone giant cell tumorSystem Organ Class: 100000004864EUCTR2008-001606-16-ATAmgen Inc530